Browsing by Author Hongmei Gao

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
1-Aug-2012Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trialsDavid C. Montefiori; Chitraporn Karnasuta; Ying Huang; Hasan Ahmed; Peter Gilbert; Mark S. De Souza; Robert McLinden; Sodsai Tovanabutra; Agnes Laurence-Chenine; Eric Sanders-Buell; M. Anthony Moody; Mattia Bonsignori; Christina Ochsenbauer; John Kappes; Haili Tang; Kelli Greene; Hongmei Gao; Celia C. Labranche; Charla Andrews; Victoria R. Polonis; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Steve G. Self; Phillip W. Berman; Donald Francis; Faruk Sinangil; Carter Lee; Jim Tartaglia; Merlin L. Robb; Barton F. Haynes; Nelson L. Michael; Jerome H. Kim; Duke University School of Medicine; Armed Forces Research Institute of Medical Sciences, San Francisco; Fred Hutchinson Cancer Research Center; Walter Reed Army Institute of Research; University of Alabama; Ministry of Public Health; Mahidol University; University of California, Santa Cruz; Global Solutions for Infectious Diseases; Sanofi Pasteur
26-Sep-2013Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy TrialRaphael Gottardo; Robert T. Bailer; Bette T. Korber; S. Gnanakaran; Joshua Phillips; Xiaoying Shen; Georgia D. Tomaras; Ellen Turk; Gregory Imholte; Larry Eckler; Holger Wenschuh; Johannes Zerweck; Kelli Greene; Hongmei Gao; Phillip W. Berman; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Merlin L. Robb; Nelson L. Michael; Jerome H. Kim; Susan Zolla-Pazner; Barton F. Haynes; John R. Mascola; Steve Self; Peter Gilbert; David C. Montefiori; Fred Hutchinson Cancer Research Center; National Institute of Allergy and Infectious Diseases; Los Alamos National Laboratory; Duke University School of Medicine; JPT Peptide Technologies GmbH; University of California, Santa Cruz; Global Solutions for Infectious Diseases; Armed Forces Research Institute of Medical Sciences, Thailand; Thailand Ministry of Public Health; Mahidol University; Department of Research and Development; Walter Reed Army Institute of Research; VA Medical Center; NYU School of Medicine
1-Nov-2012The thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120Nicos Karasavvas; Erik Billings; Mangala Rao; Constance Williams; Susan Zolla-Pazner; Robert T. Bailer; Richard A. Koup; Sirinan Madnote; Duangnapa Arworn; Xiaoying Shen; Georgia D. Tomaras; Jeffrey R. Currier; Mike Jiang; Craig Magaret; Charla Andrews; Raphael Gottardo; Peter Gilbert; Timothy J. Cardozo; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Robert Paris; Kelli Greene; Hongmei Gao; Sanjay Gurunathan; Jim Tartaglia; Faruk Sinangil; Bette T. Korber; David C. Montefiori; John R. Mascola; Merlin L. Robb; Barton F. Haynes; Viseth Ngauy; Nelson L. Michael; Jerome H. Kim; Mark S. De Souza; Armed Forces Research Institute of Medical Sciences, Thailand; HJF; Walter Reed Army Institute of Research; NYU School of Medicine; Veterans Affairs NY Harbor Healthcare System; National Institute of Allergy and Infectious Diseases; Duke University School of Medicine; Fred Hutchinson Cancer Research Center; Thailand Ministry of Public Health; Mahidol University; Walter Reed National Military Medical Center; Sanofi Pasteur; Global Solutions for Infectious Diseases; Los Alamos National Laboratory